Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC

被引：2
|
作者：
Musick, K. [1 ]
Howard, J. [2 ]
Li, G. [3 ]
Vu, T. [4 ]
Korobko, D. [5 ]
Smilowski, M. [6 ]
Liu, L. [1 ]
Steeland, S. [1 ]
Noukens, J. [7 ]
Van Hoorick, B. [1 ]
Podhorna, J. [1 ]
Li, Y. [8 ]
Utsugisawa, K. [9 ]
Sacca, F. [10 ]
Wiendl, H. [11 ]
De Bleecker, J. [12 ]
Mantegazza, R. [13 ]
机构：
[1] Argenx, Ghent, Belgium
[2] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA
[3] Medsol Clin Res Ctr Inc, Port Charlotte, FL USA
[4] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA
[5] State Novosibirsk Reg Clin Hosp, State Budgetary Healthcare Inst Novosibirsk Reg, Novosibirsk, Russia
[6] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland
[7] Curare Consulting BV, Hamburg, Germany
[8] Cleveland Clin, Cleveland, OH USA
[9] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan
[10] Federico II Univ Naples, NRSO Dept, Naples, Italy
[11] Univ Munster, Dept Neurol, Munster, Germany
[12] Ghent Univ Hosp, Ghent, Belgium
[13] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy
来源：
NEUROMUSCULAR DISORDERS | 2023年 / 33卷
关键词：
D O I：
10.1016/j.nmd.2023.07.443
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P276
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
    Kim, Yool-hee
    Shin, Ha Young
    Kim, Seung Min
    YONSEI MEDICAL JOURNAL, 2019, 60 (07) : 633 - 639
  • [32] EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIAL
    Hussain, Yessar
    Allen, Jeffrey A.
    Le Masson, Gwendal
    Suresh, Niraja
    Hewamadduma, Channa
    Lin, Jie
    Lipowska, Marta
    Lauria, Giuseppe
    Simu, Mihaela-Adriana
    Chang, Ting
    Kuwabara, Satoshi
    Guptill, Jeffrey T.
    Dysgaard, Tina
    Eggers, Christian
    Leypoldt, Frank
    MUSCLE & NERVE, 2024, 70 (03) : 537 - 537
  • [33] EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE TRIAL SUBGROUP ANALYSIS
    Allen, Jeffrey A.
    Lewis, Richard A.
    Querol, Luis
    Hussain, Yessar
    Gwathmey, Kelly
    Suresh, Niraja
    Guptill, Jeffrey T.
    Hofman, Erik
    Van Hoorick, Benjamin
    Mole, Trevor
    Kuwabara, Satoshi
    Basta, Ivana
    Van Doorn, Pieter A.
    MUSCLE & NERVE, 2024, 70 (03) : 536 - 536
  • [34] Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
    Wang, Pan
    Zhang, Bo
    Yin, Jian
    Xi, Jianying
    Tan, Ying
    Gao, Feng
    Zeng, Fan
    Chang, Ting
    Zhou, Hao
    Liang, Hui
    Zhao, Zhongyan
    Yang, Huan
    Zhao, Chongbo
    Huang, Shixiong
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [35] SAFETY AND TOLERABILITY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF INFECTION RISK AND HEMATOLOGICAL CHANGES
    Muppidi, Srikanth
    Pasnoor, Mamatha
    Gelinas, Deborah
    Brauer, Edward
    Kerstens, Rene
    Bhavaraju-Sanka, Ratna
    Howard, James
    MUSCLE & NERVE, 2022, 66 : S104 - S104
  • [36] LONG-TERM SAFETY AND EFFICACY OF ZILUCOPLAN IN GENERALIZED MYASTHENIA GRAVIS: 120-WEEK INTERIM ANALYSIS OF RAISE-XT
    Howard, James F., Jr.
    Freimer, Miriam
    Genge, Angela
    Hewamadduma, Channa
    Hussain, Yessar
    Maniaol, Angelina
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vu, Tuan
    Weiss, Michael D.
    Boroojerdi, Babak
    Duda, Petra W.
    Grimson, Fiona
    Vanderkelen, Mark
    Leite, M. Isabel
    MUSCLE & NERVE, 2024, 70 (03) : 548 - 548
  • [37] Long-term efficacy and safety of tacrolimus monotherapy for myasthenia gravis
    Itani, K.
    Wate, R.
    Kaneko, S.
    Fujita, K.
    Iida, S.
    Morise, S.
    Murakami, A.
    Oki, M.
    Tsuge, A.
    Miyake, K.
    Nakamura, M.
    Kunieda, T.
    Kusaka, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 467 - 467
  • [38] Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis
    Itani, Kumi
    Nakamura, Masataka
    Wate, Reika
    Kaneko, Satoshi
    Fujita, Kengo
    Iida, Shin
    Morise, Satoshi
    Murakami, Aya
    Kunieda, Takenobu
    Takenouchi, Norihiro
    Yakushiji, Yusuke
    Kusaka, Hirofumi
    NEUROMUSCULAR DISORDERS, 2021, 31 (06) : 512 - 518
  • [39] Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
    Howard Jr, James F.
    Bresch, Saskia
    Farmakidis, Constantine
    Freimer, Miriam
    Genge, Angela
    Hewamadduma, Channa
    Hinton, John
    Hussain, Yessar
    Juntas-Morales, Raul
    Kaminski, Henry J.
    Maniaol, Angelina
    Mantegazza, Renato
    Masuda, Masayuki
    Nowak, Richard J.
    Sivakumar, Kumaraswamy
    Smilowski, Marek
    Utsugisawa, Kimiaki
    Vu, Tuan
    Weiss, Michael D.
    Zajda, Malgorzata
    Bloemers, Jos
    Boroojerdi, Babak
    Brock, Melissa
    de la Borderie, Guillemette
    Duda, Petra W.
    Vanderkelen, Mark
    Leite, M. Isabel
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [40] LONG-TERM SAFETY AND EFFICACY OF NIPOCALIMAB IN GENERALIZED MYASTHENIA GRAVIS: VIVACITY-MG3 OPEN-LABEL INTERIM ANALYSIS
    Antozzi, Carlo
    Vu, Tuan
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    MUSCLE & NERVE, 2024, 70 (03) : 674 - 675
12345